Sepracor Inc. is a leading specialty pharmaceutical company focused on the cost-effective development of safer, purer and more effective drugs that are improved versions of widely-prescribed pharmaceutical compounds. Typically, these Improved Chemical Entities are patented, single-isomer or active-metabolite forms of the parent compound. The Company selects for development compounds with the potential to offer improvements over existing therapies with respect to efficacy, side-effect profile or both.